Low-Temperature Plasma Reduces the Risk of Abdominal Infection in Hepatocellular Carcinoma Patients

Abstract

This study aimed to explore the impact of Low-Temperature Plasma (LTP) on the risk of abdominal infection in Hepatocellular Carcinoma (HCC) patients.A total of 120 HCC patients were randomly divided into the experimental group (treated with LTP combined with traditional treatment) and the control group (treated with traditional treatment only). The incidence of abdominal infection, levels of inflammatory factors, and immune function indicators were compared between the two groups. The results showed that the incidence of abdominal infection in the experimental group was significantly lower than that in the control group (P < 0.05). The levels of inflammatory factors such as C-Reactive Protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) in the experimental group were significantly lower than those in the control group at 3 days, 7 days, and 14 days after treatment (P < 0.05).The immune function indicators including CD3+, CD4+, and the CD4+/CD8+ ratio in the experimental group were significantly higher than those in the control group at 7 days and 14 days after treatment (P < 0.05). In conclusion, LTP can effectively reduce the risk of abdominal infection in HCC patients, reduce the levels of inflammatory factors, and improve immune function.